Center for Neuroscience Initiative fosters neuroscience-related research & graduate education

Home

Welcome to the Auburn University Center for Neuroscience Initiative.

Auburn researchers work to mitigate against mental, neurological and substance use disorders, which make up a substantial
proportion of the world’s disease burden. The team of experts collaborate to increase fundamental knowledge about the brain
and nervous system and to use that knowledge to reduce the burden of neurological disease.


Upcoming Retreat – Registration is now closed. You can check the poster abstracts here . The agenda can be found here.

This image has an empty alt attribute; its file name is FINAL_CNSi-Retreat-2-1500x844.jpg

 


News

Priyanka Pinky is awarded a 2020 Predoctoral Fellowship in Pharmacology/Toxicology by the PhRMA Foundation

January 7, 2020

Priyanka Pinky – a CNS member co-advised by Drs. Vishnu Suppiramaniam and Miranda Reed – was chosen as recipient of a 2020 Predoctoral Fellowship in Pharmacology/Toxicology from the Pharmaceutical Research and Manufacturers of America (PhRMA) Foundation.

This image has an empty alt attribute; its file name is IMG_8636-4-600x900.jpg

This award provides $26,000 per year, up to two years, to support career development activities of scientists embarking on research that integrates information on molecular or cellular mechanisms of action with information on the effects of an agent observed in an intact organism, in experimental animal or clinical studies or both. Congratulations Priyanka!

Read more about the award here  and about the PhRMA Foundation here .

*********************************************************************

Novel drug development at Auburn could combat Alzheimer’s disease progression

September 20, 2019 – By Amy Weaver Office of Communications and Marketing

Raj Amin

A researcher in the Auburn University Harrison School of Pharmacy has developed a novel drug for helping to fight the progression of Alzheimer’s disease.

Raj Amin, associate professor in the Department of Drug Discovery and Development, said current drugs that activate the class of nuclear receptors, known as PPAR-gamma or peroxisome proliferator-activated receptor gamma, have traditionally been used for improving insulin sensitivity in diabetic patients…

Read  full story here

*********************************************************************

Auburn University nutrition researchers investigate promising keys to unlocking the mysteries of Alzheimer’s disease

September 19, 2019 – by Charlotte Tuggle, College of Human Sciences

Lauren Woodie in the lab.

Alzheimer’s disease affects millions of lives around the world every year according to the 2018 World Alzheimer’s Report, but both the cause and cure to the disease remain a mystery to the medical field. Auburn University College of Human Sciences researchers are tapping into the study of food and diets to examine preventative measures, possible treatments and even potential cures to the disease.

Read full story here

*********************************************************************

CNSi Graduate Research Fellowship Program winners have been announced

September 12, 2019 – By Alexis Ramos

Read full story here

*********************************************************************

Pharmacy researchers find mom’s marijuana use to impair baby’s memory

September 5, 2019 – By Amy weaver, Office of Communications and Marketing

Priyanka Pinky working in a lab

Auburn University Harrison School of Pharmacy researchers have found more and more expectant mothers are turning to marijuana and subsequently putting their baby’s memory at risk.

With a recent report claiming the number of women using marijuana during pregnancy had doubled in the last 15 years, Auburn doctoral student Priyanka Pinky sought to examine what effect it would have on the developing baby.

Read full story here

*********************************************************************

Students Win Awards at 2019 This is Research: Student Symposium

Read full story here

*********************************************************************

Bonner Named a Barry M. Goldwater Scholar; Studies Alzheimer’s Disease

April 30, 2019 – By Wade Berry, Honors College

Drew Bonner, Auburn University, College of Veterinary Medicine, Department of Anatomy, Physiology and Pharmacology, Scott-Ritchey Research Center

 Font Size 

Article body

Auburn University senior Drew Bonner is now a Barry M. Goldwater Scholar, an honor bestowed on only 496 students nationwide. The scholarship is widely considered the most prestigious award in the United States for undergraduates in science, technology, engineering and mathematics.

Bonner, originally from Birmingham, is majoring in microbial biology in the College of Sciences and Mathematics and was chosen this April from a field of nearly 5,000 college students.

Read full story here

*********************************************************************

Setti Searching for Early Markers of Alzheimer’s

April 19, 2019 – By Matt Crouch, Harrison School of Pharmacy

Sharay Setti, Auburn University, Harrison School of Pharmacy, Drug Discovery & Development

For many suffering from Alzheimer’s disease, alterations in the brain can begin 10 or more years before the appearance of symptoms and a diagnosis. Early detection in Alzheimer’s is critical and the search for those early markers drives the research of Harrison School of Pharmacy graduate student Sharay Setti.

Setti, a fourth-year doctoral student working under Dr. Miranda Reed in the Department of Drug Discovery and Development, was recently recognized for her work with a $10,000 fellowship from the American Foundation for Pharmaceutical Education. It marks the third consecutive year for Setti to receive the fellowship, which provides recognition and support for a diverse group of students as they pursue advanced pharmaceutical sciences education. Additionally, she was recently selected for one of the inaugural Auburn University Center for Neuroscience Initiative fellowships.

Read full story here

*********************************************************************

Pregnant Women are Using Marijuana for Morning Sickness. Study on Rats Suggests This Could Affect Baby’s Brain

April 9, 2019 – By Kashmira Gander – Newsweek
(Priyanka Das Pinky, a graduate student in Dr. Vishnu Suppiramaniam’s laboratory, co-authored the study.)

Using cannabis while pregnant to ease morning sickness could damage the brain of a fetus, scientists who studied rats have warned.

Between 2002 and 2014, the rates of women using cannabis during pregnancy spiked by 62 percent in the U.S., and marijuana is the psychoactive drug used most commonly by pregnant women, according to the researchers at Auburn University, in Alabama. Expectant mothers turn to the drug because it can alleviate the symptoms of morning sickness.

As more U.S. states move to legalize the drug and the stigma surrounding its use falls away, scientists wanted to investigate its potential harm to fetuses.

Read full story here


Work-in-Progress (WIP) Meetings

Join one of our groups today. Learn more details here.


Join our listserv!

Last modified: February 19, 2020